Properties
Description
Valemetostat inhibits the enzymes that add methyl groups to histone proteins, altering chromatin structure and gene expression. It targets EZH1.
Molecular Formula
C26H34ClN3O4
Solubility
DMSO: 89 mg/mL (182.36 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
Valemetostat can be used to dual-inhibit EZH1 and EZH2, relevant in the study of cancer and epigenetic regulation.
